info@mdrevenuegroup.com9:00 AM - 5:00 PM | Mon - Fri
MD Revenue Group provides specialized, high-performance revenue cycle management for independent gastroenterology practices, specialized multi-physician GI groups, and GI-focused endoscopy centers. We eliminate "Screening Leakage" by mastering the complex 2026 shifts in colorectal cancer (CRC) preventative coding, diagnostic sedation management, and specialized "Site of Service" technical logic. Our Medical Billing Services are engineered to transform your high-volume endoscopy center from a commodity billing operation into a proactive capital recovery engine.
Claim Free Gastroenterology AuditFor a high-volume GI group, the administrative debt of Credentialing across multiple hospital systems and maintaining the specialized "Screening-Logic" for various commercial payers is often the primary bottleneck to group growth. Our Medical Billing Services provide the technical scale required for large multi-site groups.
As you add new physicians, PA-C specialists, or specialized anesthesia assistants (AAs) for sedation, your billing scales instantly without the need for additional office space or in-house personnel.
By catching technical and anatomical errors (like Payer Enrollment gaps or expired facility links) *before* submission, we dramatically accelerate your cash flow for high-volume endoscopy days.
We build "Audit-Armor" into the foundation of your GI group. Our experts ensure that every endoscopy report, every conversion modifier, and every pathology correlation is "Ready for Scrutiny" before it ever leaves your facility.
Gastroenterology is a specialty defined by extreme volume and the intricate technical relationship between preventative screenings and diagnostic interventions. In 2026, the administrative friction for GI-care has reached an all-time high, with payers using advanced AI-algorithms to audit "Polyp Conversion" logic and sedation-time synchronization.
A primary source of revenue erosion for GI practices is the incorrect application of the **-33 (Preventative)** and **-PT (CRC Screening converted to diagnostic)** modifiers. In 2026, many payers have automated cross-referencing for CRC screenings that result in a biopsy or polypectomy. If the modifier-math isn't perfect, the claim is either denied entirely or the patient is incorrectly hit with a high deductible, resulting in "Bad Debt" and reputational damage. We implement Revenue Integrity protocols to ensure every conversion is accurately captured.
With the 2026 shifts in GI-directed sedation (G0500) and the increasing use of specialized anesthesia in endoscopy suites, failure to perfectly align the facility fee (POS 24/22) with the professional sedation component leads to systemic "Quiet Bundling." Most practices lose 10-15% of their total procedural margin simply by failing to satisfy these specific "Facility-to-Pro" requirements. MDRG’s Revenue Cycle Management experts specialize in technical reconciliation to avoid these automatic denials.
GI practices that perform in-office biopsies (or have high-volume lab needs) often lose revenue because the biopsy code (45380 series) doesn't perfectly match the ICD-10 pathology result. In 2026, payers are auditing for "Clinical Parity"—ensuring that a billed "Malignant Polyp" corresponds to a technical pathology report in the patient’s record.
Topical authority in GI RCM involves mastering the 40000-series CPT codes and the nuances of high-complexity endoscopic intervention. Our GI-certified coders ensure every Revenue Cycle Management submission is optimized for technical success.
Screening-to-Diagnostic modifier logic
Capture of biopsy & dilation add-ons
2026 preventative-to-diagnostic parity
High-complexity bundling & devices
Motility, pH monitoring, & CAPE-logs
Medicare Deductible-override accuracy
Commercial Payer preventative-parity
In 2026, GI billing is a battle of "Screening Integrity." Payers are no longer just looking for coding errors; they are using AI-driven auditing to challenge the *conversion* of a free screening into a paid diagnostic procedure. We defend your revenue against these three high-frequency rejection types:
Payer bots often deny colonoscopy claims if they detect a "Modifier Mismatch" between the G-code screening and the 45380 biopsy code. In 2026, if the -PT or -33 isn't applied to the biopsy line correctly, the claim fails the "Preventative Parity" check.
Many payers have updated their "Multiple Endoscopy" rules for 2026. If a surgeon removes multiple polyps using different techniques (e.g., snare vs. cold biopsy), most billing software automatically "Over-Bundles" the lower-value code.
For newer specialized GI biologics or advanced Barrett’s Esophagus treatments, payers often trigger "Experimental" denials even for FDA-cleared hardware.
In 2026, the key to GI revenue is the "Technical Intensity Narrative." We help your providers implement "Audit-Armor" charting strategies that signal authority to payer algorithms. This includes using "Trigger Phrases" for polyp-removal necessity and automating the capture of specialized sedation technical data.
We help you structure your endoscopy reports so that the "Technical Necessity" of a diagnostic conversion is undeniable to even the most aggressive automated payer bots.
We teach your team how to describe complex endoscopy work in a way that reflects the true "Procedural Intensity," reducing the risk of automated over-bundling.
MDRG acts as your practice’s "Endoscopy RCM Command Center." We focus entirely on Revenue Cycle Management efficiency so you can focus on clinical diagnostics and patient care.
We synchronize with your Endoscopy Report Writing system (e.g., ProVation, gGastro) to establish a clean, high-speed data bridge.
Every GI claim is scrubbed for 2026 CPT/Diagnosis parity before it hits the clearinghouse. We look for "Screening-to-Diagnostic Red-Flags" that AI-payers use to auto-delete high-value polypectomy lines.
We don't accept "No." We challenge every technical surgical and facility denial with clinical precision, leveraging our GI-certified coders to file high-level appeals for your most complex biliar and interventional cases.
Track your net collections, "Revenue Leakage" points, and payer performance points with total transparency via our secure portal.
To defend your GI revenue in 2026, your endoscopy records must be bulletproof. We provide our GI clients with a rigorous documentation checklist to ensure compliance:
In a technical audit for a 12-physician GI group in the Southeast, MDRG identified a $210,000 annual revenue leakage in their screening-to-diagnostic conversion and sedation billing. The group was failing to correctly apply the -PT modifier for Medicare patients and was losing the technical value of their GI-directed sedation minutes.
By implementing Revenue Cycle Management best practices—including real-time "Conversion-Capture Training" for their clinical staff—MDRG was able to: * **Recover $145,000 in uncaptured conversion and sedation revenue** within the first 6 months. * **Reduce their "Patient Cost-Sharing" Denials** by 82% using specialized technical narratives. * **Accelerate Cash Flow** by reducing their average days in A/R from 51 days to 26 days.
This GI group now operates with "Audit-Armor" protection, knowing that every high-value procedure is protected from automated payer clawbacks.
In the high-intensity environment of 2026 GI care, being "close" isn't enough. Your practice deserves a revenue cycle that is as precise as your clinical diagnostics. Don't let your "Diagnostic Value" be eroded by primitive billing and administrative friction.
Direct PDF download. We respect medical practice privacy.
Get a free audit of your billing. If we don't find money you're leaving on the table, you don't pay a dime.
